People with a history of psychosis often also have attention-deficit/hyperactivity disorder (ADHD). However, treating this ...

Every experience leaves a trace in the brain, a memory that can shape future behavior. Alcohol and other addictive substances ...

Rituximab (Rituxan) prevented relapse in patients with adult-onset frequently relapsing nephrotic syndrome (FRNS) or steroid-dependent nephrotic syndrome (SDNS), a randomized trial showed. Among 66 ...

A new method replicated the findings of a previous clinical trial of Tecfidera in people with relapsing-remitting MS, a study ...

Many older adults with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) have a relapse despite having a measurable residual disease (MRD)–negative complete remission with combination ...

Relapsing-remitting multiple sclerosis (MS) is commonly treated with parenteral drugs that can lead to adverse events and poor adherence. Three phase 3 randomized trials evaluated the efficacy and ...

A study showed that 96% of patients with schizophrenia remained relapse-free with every-6-month dosing of the long-acting injectable paliperidone palmitate (Invega Hafyera) through up to 3 years, ...

NPM1 minimal residual disease (MRD) positivity before allogeneic hematopoietic cell transplantation is linked to higher relapse rates and lower overall survival in patients with acute myeloid leukemia ...

Primary nephrotic syndrome in adults is characterized by severe proteinuria and hypoalbuminemia. This was the first clinical trial to test rituximab in adult-onset frequently relapsing nephrotic ...

People with a history of psychosis often also have attention-deficit/hyperactivity disorder (ADHD). However, treating this condition presents doctors with a clinical dilemma: psychostimulants are ...